Joong Sup Shim

18PUBLICATIONS
54CO-AUTHORS
Molecular targetsHaematological tumoursNeurology and neuromuscular diseasesMetabolic medicineCharacterisation of biological macromolecules
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|Sep 27, 2026
Triptolide sensitizes cancer cells to nucleoside DNA methyltransferase inhibitors through inhibition of DCTPP1-mediated cell-intrinsic resistance.

|Aug 19, 2026
Biallelic loss of RB1 in hepatocellular carcinoma as synthetic lethal target for artificial intelligence-guided therapy.

|Mar 06, 2026
DNA methyltransferase inhibition is a therapeutic vulnerability in VHL-deficient renal cell carcinoma cells.

Yue Pu, Ziruoyu Wang, Shishi Tao

|May 14, 2025
ARID1A loss enhances sensitivity to c-MET inhibition by dual targeting of GPX4 and iron homeostasis, inducing ferroptosis.

Xu Zhang, Zihuan Wang, Yilin He

|Jan 06, 2025
Inhibition of GSK3β is synthetic lethal with FHIT loss in lung cancer by blocking homologous recombination repair.

Shishi Tao, Yue Pu, Eun Ju Yang

|May 25, 2023
BRCA1 Insufficiency Induces a Hypersialylated Acidic Tumor Microenvironment That Promotes Metastasis and Immunotherapy Resistance.

Xiaodong Shu, Jianjie Li, Un In Chan

Pageof 3

Frequent Collaborators

2 joint publications

Kai Miao

2 joint publications

Chu-Xia Deng

1 joint publications

Hui-Yun Hwang

1 joint publications

Dasol Kim